The duration of beta‐blocker therapy and outcomes in patients without heart failure or left ventricular systolic dysfunction after acute myocardial infarction: A multicenter prospective cohort study

BACKGROUND: The duration of beta‐blocker therapy in patients without heart failure (HF) or left ventricular systolic dysfunction after acute myocardial infarction (AMI) is unclear. HYPOTHESIS: Continuous beta‐blocker therapy is associated with an improved prognosis. METHODS: This is a prospective, m...

Descripción completa

Detalles Bibliográficos
Autores principales: Wen, Xue‐Song, Luo, Rui, Liu, Jie, Liu, Zhi‐Qiang, Zhang, Han‐Wen, Hu, Wei‐Wei, Duan, Qin, Qin, Shu, Xiao, Jun, Zhang, Dong‐Ying
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2022
Materias:
Clinical Investigations
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9045069/
https://www.ncbi.nlm.nih.gov/pubmed/35246866
http://dx.doi.org/10.1002/clc.23807

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9045069/
https://www.ncbi.nlm.nih.gov/pubmed/35246866
http://dx.doi.org/10.1002/clc.23807

Ejemplares similares